Evaxion Biotech AS (EVAX)
1.49
+0.12
(+8.76%)
USD |
NASDAQ |
Nov 22, 16:00
1.42
-0.07
(-4.70%)
After-Hours: 20:00
Evaxion Biotech Revenue (Annual): 0.073M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.073M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.073M
Minimum
2023
0.073M
Maximum
2023
0.073M
Average
0.073M
Median
2023
Revenue (Annual) Benchmarks
| Ascendis Pharma AS | 288.75M |
| DBV Technologies SA | -- |
| Adaptimmune Therapeutics PLC | 60.28M |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals PLC | 0.4741M |